Current Pharmaceutical Design

William A. Banks  
Building 1, Room 810A
1600 S. Columbian Way
Seattle, WA 98108


TRPV1 Receptors in the Central Nervous System: Potential for Previously Unforeseen Therapeutic Applications

Author(s): Vincenzo Di Marzo, Katarzyna Starowicz and Luigia Cristino

Affiliation: Institute of Biomolecular Chemistry, C.N.R., Via dei Campi Flegrei 34, Comprensorio Olivetti, 80078 Pozzuoli (Naples), Italy.


Increasing evidence exists to support the presence of functional transient receptor potential vanilloid type 1 (TRPV1) channels in the brain, where these receptors are unlikely to be activated by high temperature and low pH. Here we review this evidence as well as the literature data pointing to the potential role of endovanilloid-activated brain TRPV1 channels not only in the supraspinal control of pain, body temperature, cardiovascular and respiratory functions and emesis, but also in anxiety and locomotion. This literature provides the first bases for the possible future development of new therapeutic approaches that, by specifically targeting brain TRPV1 receptors, might be used for the treatment of pain as well as affective and motor disorders.

Keywords: TRPV1, brain, central nervous system, anandamide, endovanilloid, capsaicin, vanilloid

Order Reprints Order Eprints Rights & PermissionsPrintExport

Article Details

Page: [42 - 54]
Pages: 13
DOI: 10.2174/138161208783330790